Warning letter
Scientific Protein Laboratories, LLC [ARCHIVED]: warning letter of Jan 20, 2011
FDA warning letter 144913 · Minneapolis District Office
Key facts
| Reference number | 144913 |
|---|---|
| Company | Scientific Protein Laboratories, LLC [ARCHIVED] |
| Subject | CGMP for Deviations/Adulterated |
| Issue date | Jan 20, 2011 |
| Posted date | Jan 20, 2011 |
| Issuing office | Minneapolis District Office |
| Product type | Drugs |
| CFR sections cited | 314.420 |
| Inspection city | Waunakee |
| Inspection ZIP | 53597 |
| Inspection start date | Jul 28, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: